Abstract:When Joseph Priestley discovered oxygen in 1774, he found that air was a mixture of gases. He called one of these gases “dephlogisticated air,” to which later the chemist Antoine Lavoisier gave the name “oxygen” which made candles burn brighter and longer than ordinary air [1]. Until now, this discovery covers 2 essential features of oxygen which in clinical practice results in the use of oxygen as a drug. In clinical practice, oxygen can be life-saving by giving to patients with tissue hypoxemia. However, too much oxygenation can cause toxicity, which has been well described in the literature. Oxygen toxicity in central nervous system is termed Paul Bert effect and in the lung it is termed Lorrain Smith effect. The Paul Bert effect results in seizures from which the onset depends upon the partial pressure of oxygen in the breathing gas and exposure duration. This effect is well known among divers and in hyperbaric facilities. Respiratory side effects from oxygen are more frequently observed in critical care settings resulting in a restrictive policy not to administer more oxygen than required. In this context, however, it is important to have the formulae of oxygen content in mind while not just relying on the oxygen saturation values (arterial oxygen content = (Hb × 1.34 × SaO 2 ) + (0.0031 × PaO 2 )). Additionally, NICU patients are potentially at risk for Terry’s syndrome or retinopathy of prematurity, a disease of the eye when oxygen is administered for premature development of the lungs. Although oxygen is a natural molecule, the complexity of its interactions with human metabolism continues to be a subject for in-depth research [2]. In this thematic issue of oxygen therapy and ventilatory support (OTVS), several papers investigated and discussed some key aspects in the field of respiratory failure and ventilator support. J.-L. Vincent et al. published an article addressing the harmful effect of hyperoxia on critical illness. It has been reported that the effect of partial pressure of arterial oxygenation on mortality follows a quadratic function [3], and there is nadir at which the mortality rate is the lowest. Respiratory support can be performed by a variety of techniques, ranging from the simple oxygen therapy to complex extracorporeal membrane oxygenation (ECMO). In patients with ECMO, the mechanical ventilation usually plays an important role. The appropriate setting of the ventilator is of vital importance to provide oxygen supply to vital organs while avoiding lung injury. It is an art and science where, in most circumstances, there is a lack of high-level evidence from randomized controlled trials. Z. Zhang and colleagues discussed some important aspects on the use of mechanical ventilation in patients with ECMO. S. Ye and his colleagues investigated the effect of antipyretic therapy on mortality outcome in patients receiving mechanical ventilation. The study employed the MIMIC-II database as the source of data [4]. The database is freely available to the public and is the gold standard of the critical care big data. It provides in-hospital clinical data with high granularity, and data mining using such database can provide insights into complex interactions between disease severity, medical treatment, and procedures. Such complex interactions may not be feasible in conventional randomized controlled trials (RCTs). Also, traditional RCTs are designed to explore the biological efficacy of a certain intervention, which may not be applicable to real world settings where the clinical effectiveness is most highlighted. There is evidence that the results obtained fromRCTs can be different from that obtained by observational studies [5].

Oxygenation management during veno-arterial ECMO support for cardiogenic shock: a multicentric retrospective cohort study

Physiologic Effects of Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome

Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation

Pao 2 and Mortality in Neonatal Extracorporeal Membrane Oxygenation: Retrospective Analysis of the Extracorporeal Life Support Organization Registry, 2015–2020

Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis

Oxygen Therapy and Ventilatory Support

Extracorporeal Membrane Oxygenation Support As Treatment For Cardiogenic Shock: Treatment Strategies And Analysis Of Risk Factors

Prognostic echocardiographic findings in patients supported with venoarterial extracorporeal membrane oxygenation for cardiogenic shock

Ultra-Protective Ventilation Reduces Biotrauma in Patients on Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome

Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis

Survival To Discharge Among Cardiogenic Shock Patients Supported By VA-ECMO: An Insight From The Largest VA-ECMO Experience In The Middle East-Gulf Region

Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial

An investigation into the contributing factors to survival of ARDS patients supported by veno-venous ECMO

The physiology of venoarterial extracorporeal membrane oxygenation - A comprehensive clinical perspective

Venovenous Extra-Corporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome: a Matched Cohort Study

Unmasking the Impact of Oxygenator Induced Hypocapnia on Blood Lactate in Veno-Arterial Extracorporeal Membrane Oxygenation

Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry

Outcomes following additional drainage during veno-venous extracorporeal membrane oxygenation: A single-center retrospective study

Mechanical ventilation during extracorporeal membrane oxygenation support – New trends and continuing challenges

Long term outcome in patients treated with veno-venous extracorporeal membrane oxygenation: A prospective observational study

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France